VONWILLEBRAND-FACTOR AND THE ENDOTHELIUM .2.

被引:86
作者
WAGNER, DD
BONFANTI, R
机构
[1] Center of Hemostasis and Thrombosis Research, Division of Hematology-Oncology, New England Medical Center, Boston, Massachusetts
关键词
D O I
10.1016/S0025-6196(12)60522-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Endothelial cells are the principal source of plasma and basement membrane von Willebrand factor (vWF). To arrive at its biologically active multimeric form, vWF undergoes a series of intracellular processing steps. The protein is synthesized as a large precursor pro-vWF, which dimerizes in the endoplasmic reticulum through disulfide bonds located in the carboxyl-terminal portion of the subunit. Only dimers are transported to the Golgi apparatus. Expression of truncated pro-vWF subunits, which lack the last 20 kd, abolishes the requirement for dimerization and thereby allows the monomeric protein to be secreted. Another requirement for intracellular transport from the endoplasmic reticulum is N-linked glycosylation. Inhibition of N-linked glycosylation prevents exit of both the wild-type and the truncated vWF from the endoplasmic reticulum. In the acidic environment of the trans-Golgi and post-Golgi compartments, pro-vWF dimers multimerize by a second set of interchain disulfide bonds. The presence of the vWF propolypeptide and acidic pH conditions are necessary for the multimerization process. The largest vWF multimers are stored in endothelial cell-specific organelles called Weibel-Palade bodies. At the site of vascular injury and inflammation, physiologic secretagogues such as thrombin, fibrin, and histamine may cause release of these large, biologically potent vWF multimers from the Weibel-Palade bodies into the surrounding blood and subendothelium.
引用
收藏
页码:621 / 627
页数:7
相关论文
共 25 条
[1]  
BONFANTI R, 1989, BLOOD, V73, P1109
[2]   NUCLEOTIDE-SEQUENCE OF PRE-PRO-VONWILLEBRAND FACTOR CDNA [J].
BONTHRON, D ;
ORR, EC ;
MITSOCK, LM ;
GINSBURG, D ;
HANDIN, RI ;
ORKIN, SH .
NUCLEIC ACIDS RESEARCH, 1986, 14 (17) :7125-7127
[3]  
CRAMER EM, 1985, BLOOD, V66, P710
[4]   THE RELATIONSHIP OF N-LINKED GLYCOSYLATION AND HEAVY-CHAIN BINDING-PROTEIN ASSOCIATION WITH THE SECRETION OF GLYCOPROTEINS [J].
DORNER, AJ ;
BOLE, DG ;
KAUFMAN, RJ .
JOURNAL OF CELL BIOLOGY, 1987, 105 (06) :2665-2674
[5]   SEQUENCE OF PROTEIN DISULFIDE ISOMERASE AND IMPLICATIONS OF ITS RELATIONSHIP TO THIOREDOXIN [J].
EDMAN, JC ;
ELLIS, L ;
BLACHER, RW ;
ROTH, RA ;
RUTTER, WJ .
NATURE, 1985, 317 (6034) :267-270
[6]   CHANGES IN CYTOSOLIC CA-2+ASSOCIATED WITH VONWILLEBRAND-FACTOR RELEASE IN HUMAN-ENDOTHELIAL CELLS EXPOSED TO HISTAMINE - STUDY OF MICROCARRIER CELL MONOLAYERS USING THE FLUORESCENT-PROBE INDO-1 [J].
HAMILTON, KK ;
SIMS, PJ .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 79 (02) :600-608
[7]  
HATTORI R, 1989, J BIOL CHEM, V264, P7768
[8]   PADGEM PROTEIN - A RECEPTOR THAT MEDIATES THE INTERACTION OF ACTIVATED PLATELETS WITH NEUTROPHILS AND MONOCYTES [J].
LARSEN, E ;
CELI, A ;
GILBERT, GE ;
FURIE, BC ;
ERBAN, JK ;
BONFANTI, R ;
WAGNER, DD ;
FURIE, B .
CELL, 1989, 59 (02) :305-312
[9]  
LEVINE JD, 1982, BLOOD, V60, P531
[10]   THE EFFECT OF CALCIUM ON THE SECRETION OF FACTOR-VIII-RELATED ANTIGEN BY CULTURED HUMAN-ENDOTHELIAL CELLS [J].
LOESBERG, C ;
GONSALVES, MD ;
ZANDBERGEN, J ;
WILLEMS, C ;
VANAKEN, WG ;
STEL, HV ;
VANMOURIK, JA ;
DEGROOT, PG .
BIOCHIMICA ET BIOPHYSICA ACTA, 1983, 763 (02) :160-168